Benjamin et al. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598, 1998.* |
Vukicevic et al. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci USA 93: 9021-9026, 1996.* |
Massague et al. The TGF-beta family of growth and differentiation factors. Cell 49: 437-438, 1987.* |
Pilbeam et al. Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on resorption and formation in organ culture. Bone 14: 717-720, 1993.* |
Alberts et al. Molecular Biology of the Cell, New York: Garland Publishing, 1994.* |
Ngo et al. Computational complexity, protein structure prediction, and the Levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495, 1994.* |
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotech 18(1): 34-39, 2000.* |
Bork, A. Powers and pitfalls in sequence analysis: the 70% hurdle. Genome Res 10: 398-400, 2000.* |
Doerks et al. Protein annotation: detective work for function prediction. Trends in Genetics 14(6): 248-250, 1998.* |
Smith et al. The challenges of genome sequence annotation or “The devil is in the details”. Nature Biotech 15: 1222-1223, 1997.* |
Brenner, S.E. Errors in genome function. Trends in Genetics 15(4): 132-133, 1999.* |
Bork et al. Go hunting in sequence databases but watch out for the traps. Trends in Genetics. 12(10): 425-427, 1996.* |
Wells. J.A. Additivity of mutational effects in proteins. Biochemistry 29 (37): 8509-8517, 1990.* |
Hromas, Robert et al., “Cloning of BRAK, a Novel Divergent CXC Chemokine Preferentially Expressed in Normal versus Malignant Cells,” Biochemical and Biophysical Chemical Research Communication, vol. 255, pp. 703-706 (1999). |
Cao, Xuetao et al., “Molecular Cloning and Characterization of a Novel CXC Chemokine Macrophage Inflammatory Protein-2γ Chemoattractant for Human Neutrophils and Dendritic Cells,” The Journal of Immunology, vol. 165, No. 5, pp. 2588-2595 (Sep. 1, 2000). |
GenBank (ESTs) Accession No. AI412233 (Feb. 9, 1999). |
GenBank (ESTs) Accession No. AA850731 (Apr. 30, 1998). |
GenBank (ESTs) Accession No. AI299847 (Jan. 29, 1999). |
GenBank (ESTs) Accession No. W97325 (Jul. 16, 1996). |
GenBank (ESTs) Accession No. AA111146 (Nov. 6, 1996). |
GenBank (ESTs) Accession No. AI037414 (Jun. 26, 1998). |
GenBank (ESTs) Accession No. AI282114 (Feb. 1, 1999). |
GenBank (ESTs) Accession No. AA865643 (Apr.29, 1998). |
GenBank (ESTs) Accession No. AI140104 (Apr. 13, 1999). |
GenBank (ESTs) Accession No. AA726580 (Jan. 2, 1998). |
GenBank (ESTs) Accession No. AA407924 (Aug. 26, 1998). |
GenBank (ESTs) Accession No. AA498629 (Jul. 1, 1997). |
GeneBank Accession No. AX136565, submitted Jan. 10, 2001. |
GeneBank Accession No. AX136297, submitted Jan. 10, 2001. |
EMBL Accession No. AC008119, submitted Oct. 9, 1999. |
GeneBank Accession No. AR074144, submitted Sep. 14, 1999. |
GeneBank Accession No. AX026540, submitted Jul. 13, 2000. |
EMBL Accession No. UCAJ4935, submitted Mar. 2, 1999. |
GeneBank Accession No. AX014842, submitted Oct. 21, 1999. |
GeneBank Accession No. AX078375, submitted Feb. 1, 2001. |
GeneBank Accession No. AX084211, submitted Feb. 15, 2001. |
EMBL Accession No. AF169677, submitted Jan. 29, 2000. |
EMBL Accession No. M99485, submitted Aug. 20, 1992. |
EMBL Accession No. D50030, submitted Apr. 14, 2000. |
GenPept Accession No. CAB53702, submitted Feb. 18, 2000. |